Scoot ropes in employees and consumers for genetic science experiment

Scoot, Singapore-based long-haul low-cost carrier, is partnering with Genetics, Human Biology and Neuroscience expert, Richard Paul Ebstein of the National University of Singapore, to prove how travel is embedded in our blood.

Engaging Scoot employees and consumers alike, the airline is embarking on an industry-first experiment to prove that travel is an innate human need – and not just a want – something Scoot refers to as Wandermust.

“With the Wandermust Experiment, our goal is to use science to show that travel is an intrinsic need, rather than just a luxury. By gaining deeper insights into the preferences and habits of our customers, we can continue working toward our goal of making travel attainable for everyone,” Lee Lik Hsin, CEO of Scoot said. “This partnership with Dr. Ebstein also reinforces our commitment to continuously empower consumers so they can fully embrace their Wandermust.”

As more and more consumers embrace their need to travel, Scoot understands that this has also brought about the recent day trend of people, especially young people, being criticised or judged for travelling “too much”. As part of the experiment, Ebstein, who has extensively studied the DRD4- 2/7R gene (carried by approximately 20% of the population) and its link to novelty-seeking behaviours such as travelling, will specifically look into the role of genetics as well as the impact of cultural influences.

As part of the experiment, Scoot is looking for ardent travellers who are willing to volunteer to be part of this scientific experiment. Aside from discovering whether travel is in their blood, participants also stand a chance to win 100,000 KrisFlyer miles – all the better to indulge their Wandermust with! To learn more about this experiment, watch the video.

“I’m excited to hear from the seasoned travellers from around the world – to better understand their nature and especially their innate need to travel through the Wandermust Experiment”, said Prof. Richard Ebstein. “It’s encouraging to see that an airline like Scoot is pioneering in showing how travel might be in our blood using cutting edge molecular genetic tools.”


Read More News